Daniel Palmer

2.7k total citations · 1 hit paper
27 papers, 2.1k citations indexed

About

Daniel Palmer is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Daniel Palmer has authored 27 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Daniel Palmer's work include Phosphodiesterase function and regulation (10 papers), Receptor Mechanisms and Signaling (7 papers) and Renin-Angiotensin System Studies (6 papers). Daniel Palmer is often cited by papers focused on Phosphodiesterase function and regulation (10 papers), Receptor Mechanisms and Signaling (7 papers) and Renin-Angiotensin System Studies (6 papers). Daniel Palmer collaborates with scholars based in United States, Canada and Denmark. Daniel Palmer's co-authors include Donald H. Maurice, Shaun R. Coughlin, Yoga Srinivasan, Sandra L. Jimmo, Douglas G. Tilley, Daniel R. Raymond, Ivo Cornelissen, Tovo David, Daniel N. Duong and Stuart J. Netherton and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Daniel Palmer

27 papers receiving 2.1k citations

Hit Papers

High-resolution crystal structure of human protease-activ... 2012 2026 2016 2021 2012 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Palmer United States 19 1.4k 359 356 341 305 27 2.1k
Antonio Feliciello Italy 37 2.4k 1.7× 330 0.9× 351 1.0× 508 1.5× 219 0.7× 67 3.5k
Fernand Gobeil Canada 31 1.2k 0.8× 318 0.9× 307 0.9× 521 1.5× 351 1.2× 77 2.7k
Cristina Murga Spain 27 2.5k 1.8× 285 0.8× 439 1.2× 626 1.8× 249 0.8× 52 3.2k
Minoru Seto Japan 27 1.5k 1.0× 454 1.3× 666 1.9× 366 1.1× 166 0.5× 53 2.8k
Barrie Ashby United States 25 819 0.6× 381 1.1× 252 0.7× 370 1.1× 135 0.4× 47 1.9k
Saptarsi M. Haldar United States 30 2.3k 1.6× 669 1.9× 677 1.9× 97 0.3× 293 1.0× 54 3.6k
Karsten Spicher Germany 30 2.2k 1.5× 252 0.7× 295 0.8× 992 2.9× 280 0.9× 58 3.1k
Sylvie Cazaubon France 22 1.2k 0.8× 135 0.4× 299 0.8× 261 0.8× 296 1.0× 35 2.3k
Kay Barnes United Kingdom 25 1.0k 0.7× 186 0.5× 602 1.7× 185 0.5× 235 0.8× 36 2.0k
Tammy M. Seasholtz United States 17 1.4k 1.0× 229 0.6× 331 0.9× 206 0.6× 130 0.4× 25 1.8k

Countries citing papers authored by Daniel Palmer

Since Specialization
Citations

This map shows the geographic impact of Daniel Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Palmer more than expected).

Fields of papers citing papers by Daniel Palmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Palmer. The network helps show where Daniel Palmer may publish in the future.

Co-authorship network of co-authors of Daniel Palmer

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Palmer. A scholar is included among the top collaborators of Daniel Palmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Palmer. Daniel Palmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palmer, Daniel, et al.. (2025). A synthetic chronogenetic gene circuit for programmed circadian drug delivery. Nature Communications. 16(1). 1457–1457. 4 indexed citations
2.
Palmer, Daniel, et al.. (2019). Identification of a novel scaffold for a small molecule GPR139 receptor agonist. Scientific Reports. 9(1). 3802–3802. 8 indexed citations
3.
Palmer, Daniel, et al.. (2018). MC4R Agonists: Structural Overview on Antiobesity Therapeutics. Trends in Pharmacological Sciences. 39(4). 402–423. 43 indexed citations
4.
King, J. E., Daniel Palmer, Paul J. Ross, et al.. (2013). UK audit of sorafenib for advanced hepatocellular cancer. 1 indexed citations
5.
Zhang, Cheng, Yoga Srinivasan, Daniel H. Arlow, et al.. (2012). High-resolution crystal structure of human protease-activated receptor 1. Nature. 492(7429). 387–392. 361 indexed citations breakdown →
6.
Yang, Huanghe, Andrew Kim, Tovo David, et al.. (2012). TMEM16F Forms a Ca2+-Activated Cation Channel Required for Lipid Scrambling in Platelets during Blood Coagulation. Cell. 151(1). 111–122. 348 indexed citations
7.
Green, Jesse A., Kazuhiro Suzuki, Daniel Palmer, et al.. (2011). The sphingosine 1-phosphate receptor S1P2 maintains the homeostasis of germinal center B cells and promotes niche confinement. Nature Immunology. 12(7). 672–680. 210 indexed citations
9.
Cornelissen, Ivo, Daniel Palmer, Tovo David, et al.. (2010). Roles and interactions among protease-activated receptors and P2ry12 in hemostasis and thrombosis. Proceedings of the National Academy of Sciences. 107(43). 18605–18610. 39 indexed citations
10.
Camerer, Eric, Jean B. Regard, Ivo Cornelissen, et al.. (2009). Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. Journal of Clinical Investigation. 119(7). 1871–9. 297 indexed citations
11.
Palmer, Daniel, Sandra L. Jimmo, Daniel R. Raymond, et al.. (2007). Protein Kinase A Phosphorylation of Human Phosphodiesterase 3B Promotes 14-3-3 Protein Binding and Inhibits Phosphatase-catalyzed Inactivation. Journal of Biological Chemistry. 282(13). 9411–9419. 43 indexed citations
12.
Wang, Ping, Jim E. Cutler, J. W. B. King, & Daniel Palmer. (2004). Mutation of the Regulator of G Protein Signaling Crg1 Increases Virulence in Cryptococcus neoformans. Eukaryotic Cell. 3(4). 1028–1035. 56 indexed citations
13.
Maurice, Donald H., Daniel Palmer, Douglas G. Tilley, et al.. (2003). Cyclic Nucleotide Phosphodiesterase Activity, Expression, and Targeting in Cells of the Cardiovascular System. Molecular Pharmacology. 64(3). 533–546. 252 indexed citations
15.
Netherton, Stuart J., Sandra L. Jimmo, Daniel Palmer, et al.. (2002). Altered Phosphodiesterase 3-Mediated cAMP Hydrolysis Contributes to a Hypermotile Phenotype in Obese JCR:LA-cp Rat Aortic Vascular Smooth Muscle Cells. Diabetes. 51(4). 1194–1200. 24 indexed citations
17.
Liu, Hanguan, Daniel Palmer, Sandra L. Jimmo, et al.. (2000). Expression of Phosphodiesterase 4D (PDE4D) Is Regulated by Both the Cyclic AMP-dependent Protein Kinase and Mitogen-activated Protein Kinase Signaling Pathways. Journal of Biological Chemistry. 275(34). 26615–26624. 66 indexed citations
19.
Palmer, Daniel, Keith Tsoi, & Donald H. Maurice. (1998). Synergistic Inhibition of Vascular Smooth Muscle Cell Migration by Phosphodiesterase 3 and Phosphodiesterase 4 Inhibitors. Circulation Research. 82(8). 852–861. 74 indexed citations
20.
ROSE, R. J., et al.. (1997). Cyclic AMP‐mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity. British Journal of Pharmacology. 122(2). 233–240. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026